Latest Articles

Kiwi scientists develop powerful melanoma research tool

Kiwi scientists develop powerful melanoma research tool

16 July 2020

A nationwide group of researchers from the Maurice Wilkins Centre has recently reported a detailed characterisation of one of the largest melanoma cell line panels ever developed that makes this a resource for research of international importance.

read more

MWC assisting with Samoa’s COVID-19 testing

MWC assisting with Samoa’s COVID-19 testing

5 July 2020

The Maurice Wilkins Centre has been working with the Scientific Research Organisation of Samoa (SROS) to obtain relevant equipment and protocols required for COVID-19 testing in Samoa.

read more

Getting New Zealand's only COVID-19 lab up and running

Getting New Zealand's only COVID-19 lab up and running

10 June 2020

While most of the country was in lockdown, a small team led by MWC investigators Professor Miguel Quiñones-Mateu and Associate Professor James Ussher were in their University of Otago lab working to isolate the COVID-19 virus from New Zealand patient samples. 

read more

MWC investigator backs COVID-19 vaccine search

MWC investigator backs COVID-19 vaccine search

27 May 2020

New Zealand scientists have already identified a number of potential COVID-19 vaccine candidates, according to Associate Professor James Ussher, MWC Associate Investigator at the University of Otago.

read more

COVID-19 antibody testing underway in MWC labs

COVID-19 antibody testing underway in MWC labs

22 May 2020

MWC Principal Investigator Dr Nikki Moreland, Immunologist and Senior Lecturer at the University of Auckland, is working with a team of researchers on lab-based COVID-19 antibody tests in a bid to better understand the body's immune response to the virus.

read more

MWC researchers identify novel drug target for TB

MWC researchers identify novel drug target for TB

14 May 2020

Several researchers from the Maurice Wilkins Centre are co-authors on a recent paper reporting a novel mechanism for controlling the synthesis of essential vitamin K2 in the bacterial pathogen that causes tuberculosis.

read more

MWC team awarded funding for COVID-19 research

MWC team awarded funding for COVID-19 research

3 May 2020

MWC researchers at the University of Auckland have been awarded Auckland Medical Research Foundation (AMRF) funding to investigate whether certain types of patent could be used for COVID-19 antiviral drug development.  

read more

MWC link to promising COVID-19 treatment

MWC link to promising COVID-19 treatment

24 April 2020

Professor Peter Tyler, MWC Associate Investigator at the Ferrier Research Institute, Victoria University of Wellington, created the antiviral drug Galidesivir which is in the front-running for potential use in the treatment of COVID-19.

read more